sp movement, page-14

it's a sea of red out there with all sectors under pressure. But, MSB is pretty buoyant - I'm thinking the market is believing in MSB. This is why MSB is a different type of listed animal, it doesn't have dividends, sales or profit stream, very few of the shares are actually available for trade as most held by institutions who haven't let go despite MacBank et al negative views and shortening.

But the fact that it's still at $6 and no bad announcements gives me confidence to hold.

Also, the amount of money spent world wide on stem cell tech is in tens of billions of dollars, and MSB is one of the clear leaders. This is passing spec status every day.